🇺🇸 Standard twice daily tacrolimus in United States

Standard twice daily tacrolimus (Standard twice daily tacrolimus) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Standard twice daily tacrolimus in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Standard twice daily tacrolimus approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Standard twice daily tacrolimus in United States?

University Hospital Birmingham NHS Foundation Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.